Form 8-K - Current report:
SEC Accession No. 0001005477-00-001738
Filing Date
2000-02-28
Accepted
2000-02-28 00:00:00
Documents
2
Period of Report
2000-02-24
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K 8-K 3116
2 PRESS RELEASE EX-20.1 3299
  Complete submission text file 0001005477-00-001738.txt   8014
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 555023
SIC: 2836 Biological Products, (No Diagnostic Substances)